| 溶解性 | DMSO 3 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
| 存贮条件 | 储存温度-20°C |
| 备注 | CCT129202 is an ATP-competitive pan-Aurora inhibitor for Aurora A, Aurora B and Aurora C with IC50 of 0.042 μM, 0.198 μM and 0.227 μM, respectively. It is less potent to FGFR3, GSK3β, PDGFRβ, etc. |
| 生化机理 | CCT129202 is a Aurora kinase inhibitor with IC50 of 0.042 ± 0.022, 0.198 ± 0.05, and 0.227 ± 0.064 μmol/L for Aurora A, Aurora B, and Aurora C, respectively. |
| 别名 | 2-(4-(6-chloro-2-(4-(dimethylamino)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide;2-(4-(6-chloro-2-(4-(dimethylamino)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide |
CCT129202
CCT129202 （订货以英文为准）
编号：C127546
CAS号：942947-93-5
分子式：C23H25CLN8OS
分子量：497.02
| 产品名称 | CCT129202 |
| 中文名称 | CCT129202 |
| CAS号 | 942947-93-5 |
| 分子式（M.F.） | C23H25CLN8OS |
| 分子量（M.W.） | 497.02 |
| 储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 100.00
F446500-1个
¥ 45.00
SD-0000-012-1个
小艺 
